Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,166 | 664 | 68.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,775 | 5 | 28.0% |
| Education | $552.16 | 11 | 2.7% |
| Travel and Lodging | $129.96 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $7,047 | 47 | $0 (2024) |
| Astellas Pharma US Inc | $2,118 | 98 | $0 (2024) |
| ABBVIE INC. | $1,259 | 52 | $0 (2024) |
| Janssen Biotech, Inc. | $1,101 | 63 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $1,059 | 38 | $0 (2024) |
| Blue Earth Diagnostics Limited | $809.68 | 26 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $628.02 | 34 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $622.20 | 32 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $512.43 | 36 | $0 (2024) |
| Amgen Inc. | $372.01 | 25 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,254 | 98 | ABBVIE INC. ($584.53) |
| 2023 | $2,543 | 100 | ABBVIE INC. ($518.00) |
| 2022 | $6,165 | 109 | BOSTON SCIENTIFIC CORPORATION ($4,023) |
| 2021 | $1,713 | 103 | Janssen Biotech, Inc. ($244.91) |
| 2020 | $3,178 | 49 | Boston Scientific Corporation ($2,413) |
| 2019 | $2,271 | 89 | Astellas Pharma US Inc ($484.02) |
| 2018 | $1,516 | 82 | Astellas Pharma US Inc ($378.99) |
| 2017 | $984.72 | 51 | Astellas Pharma US Inc ($268.57) |
All Payment Transactions
681 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/23/2024 | Cycle Pharmaceuticals Inc | Tiopronin (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: UROLOGY | ||||||
| 12/18/2024 | Endo USA, Inc. | AVEED (Biological) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: UROLOGY | ||||||
| 12/05/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Oncology | ||||||
| 11/25/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: UROLOGY | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.10 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/13/2024 | PFIZER INC. | TALZENNA (Drug), XTANDI | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: UROLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.55 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/23/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Oncology | ||||||
| 10/18/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.10 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/08/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: UROLOGY | ||||||
| 10/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: Oncology | ||||||
| 09/18/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/16/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $32.30 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.80 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 4,684 | 20,655 | $964,811 | $291,290 |
| 2022 | 33 | 4,579 | 17,911 | $971,635 | $286,320 |
| 2021 | 33 | 4,502 | 17,846 | $1.0M | $290,818 |
| 2020 | 40 | 4,342 | 16,652 | $944,943 | $252,022 |
All Medicare Procedures & Services
139 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 851 | 1,328 | $318,720 | $123,612 | 38.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 22 | 165 | $132,000 | $22,103 | 16.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 82 | 118 | $53,100 | $20,544 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 320 | 355 | $58,100 | $18,745 | 32.3% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 601 | 869 | $50,402 | $15,515 | 30.8% |
| J3145 | Injection, testosterone undecanoate, 1 mg | Office | 2023 | 11 | 9,750 | $29,250 | $13,728 | 46.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 94 | 94 | $34,310 | $11,293 | 32.9% |
| 53440 | Creation of sling around urethra in male to control leakage | Facility | 2023 | 15 | 15 | $32,280 | $8,696 | 26.9% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 32 | 32 | $46,560 | $8,298 | 17.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 643 | 973 | $11,676 | $8,148 | 69.8% |
| 53445 | Insertion of inflatable urethra or bladder neck sphincter | Facility | 2023 | 11 | 11 | $25,300 | $6,473 | 25.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 755 | 1,141 | $9,128 | $3,839 | 42.1% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 31 | 48 | $17,040 | $3,357 | 19.7% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 46 | 51 | $13,005 | $2,740 | 21.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 272 | 328 | $37,620 | $2,492 | 6.6% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 64 | 96 | $7,104 | $2,428 | 34.2% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 79 | 91 | $7,280 | $2,081 | 28.6% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 359 | 504 | $7,560 | $1,982 | 26.2% |
| 51705 | Simple change of bladder tube | Office | 2023 | 13 | 27 | $5,805 | $1,936 | 33.4% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 30 | 42 | $9,030 | $1,819 | 20.1% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 14 | 16 | $9,500 | $1,810 | 19.1% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 26 | 718 | $2,872 | $1,622 | 56.5% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 11 | 11 | $5,874 | $1,582 | 26.9% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 20 | 20 | $8,000 | $1,512 | 18.9% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 33 | 51 | $6,885 | $1,378 | 20.0% |
About Dr. David Miller, M.D
Dr. David Miller, M.D is a Urology healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710941117.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Miller, M.D has received a total of $20,623 in payments from pharmaceutical and medical device companies, with $2,254 received in 2024. These payments were reported across 681 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($14,166).
As a Medicare-enrolled provider, Miller has provided services to 18,107 Medicare beneficiaries, totaling 73,064 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 139 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Richmond, VA
- Active Since 04/13/2006
- Last Updated 10/28/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1710941117
Products in Payments
- AdVance XP (Device) $3,802
- AMS (Device) $2,703
- BOTOX (Biological) $1,124
- PROVENGE (Drug) $1,059
- XTANDI (Drug) $745.72
- Axumin (Drug) $681.33
- GEMTESA (Drug) $647.54
- Erleada (Drug) $646.40
- Xtandi (Drug) $474.75
- ERLEADA (Drug) $424.67
- XIAFLEX (Biological) $415.16
- Nubeqa (Drug) $398.90
- ORGOVYX (Drug) $383.26
- MYRBETRIQ (Drug) $338.64
- Prolia (Biological) $309.20
- General - Erectile Dysfunction (Device) $302.17
- UroLift (Device) $301.75
- Myrbetriq (Drug) $247.77
- JELMYTO (Drug) $232.58
- Xofigo (Drug) $229.12
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Richmond
Dr. Anthony Sliwinski, M.d, M.D
Urology — Payments: $76,833
Dr. Lonny Green, M.d, M.D
Urology — Payments: $65,404
Dr. John Delisio, M.d, M.D
Urology — Payments: $38,212
Dr. Eugene Kramolowsky, M.d, M.D
Urology — Payments: $30,695
Dr. Charles Seabury, M.d, M.D
Urology — Payments: $27,026
Dr. Michael Franks, Md, MD
Urology — Payments: $24,609